Industry News
Plant-Based Food Trend May Lead to Choline Deficiencies
A recent study suggests that the push toward only plant-based diets, without professional nutritional counseling, guidance, and supplementation, may lead to choline deficiencies beyond what is already present. The warning comes from a recent
Commentary from Lisa C. Andrews, MEd, RD, LD on “Physicians Call for Peers to Get Nutrition Education”
Dear Today’s Practitioner, I am writing in response to the article titled Dr. Neal Barnard and other Physicians Call for Peers to Get Nutrition Education in the July issue of Today’s Practitioner. I was very
Glenn Sabin: Joe Biden’s So-Far Missed Opportunity to Impact Cancer
[Disclosure: My explorations of politics on this blog are limited to how political courage and well-expended political capital can have a sustainable impact on reducing our current cancer burden. ~ Glenn Sabin] Given former
The Lancet Journals Announce Diversity Pledge and No “Manel” Policy
As part of the Lancet Group’s commitment to increasing gender equity, diversity, and inclusion in research and publishing, all of the publishing group’s 18 medical journals have adopted a new Diversity Pledge and No
FDA Announces Early Fall Cannabidiol Hearings and Clarifies Commitment to Enforcement
The FDA announced that it will host further cannabidiol hearing on the regulatory structure of CBD products in the early fall. The news was embedded in a press release regarding a warning issued to
FDA Approves Qualified Health Claim for Omega-3 Fatty Acids
Omega-3 fatty acids just received a stamp of approval from FDA for their ability to reduce the risk of hypertension and heart disease. The agency approved a qualified-health claim for Omega 3 fatty acids
Today’s Practitioner Congratulates Joshua Mansour, MD in “40 Under 40” Cancer Award
We are honored to congratulate Today’s Practitioner contributor Joshua Mansour, M.D., who was named one of forty of the nation’s most promising young oncology professionals and recognized during the 2nd annual ‘40 Under 40
International Cannabinoid Research Society (ICRS) Names Cannabis and Cannabinoid Research Its Official Journal
New Rochelle, NY, May 7, 2019—Cannabis and Cannabinoid Research (CCR) is extremely excited to announce that the International Cannabinoid Research Society (ICRS) has named CCR its Official Journal. The ICRS is a foremost international
Biotics Research Corporation, Newest GOED Member
Recently, Biotics Research became the first professional supplement brand in the United States to join the ranks of GOED membership. Formed in 2007, GOED, the Global Organization of EPA and DHA Omega-3s, is comprised
Integrative Healthcare Goes to Washington with the Congressional Integrative Health and Wellness Caucus
Capitol Hill Legislators and Staffers Get a Hands-On Introduction to Integrative Medicine WASHINGTON DC – On March 6, 2019, the second annual Congressional Integrative Health and Wellness Caucus, co-led by Rep. Judy Chu (D-CA),
FDA Commissioner Scott Gottlieb, M.D. on Public Hearing for Cannabis-containing and Cannabis-derived Products
Statement from FDA Commissioner Scott Gottlieb, M.D., on new steps to advance agency’s continued evaluation of potential regulatory pathways for cannabis-containing and cannabis-derived products In recent years, we’ve seen a growing interest in the
Ned Sharpless, MD, from National Cancer Institute (NCI), is Acting Commissioner of the Food and Drug Administration
The White House recently announced its intention to appoint Dr. Ned Sharpless, current director of the National Cancer Institute (NCI), as acting commissioner of the Food and Drug Administration (FDA). Dr. Doug Lowy, current
FDA Commissioner Scott Gottlieb MD Stepping Down
In a surprise announcement, Food and Drug Commissioner Scott Gottlieb MD announced his planned resignation this week, to go into effect in April. Gottlieb became known for his tough stance on tobacco and e-cigarettes
Exclusive Interview with Dr. Paul Anderson: The FDA and the Fate of Compounded Medicines
The following is an excerpt of interview with Paul Anderson, ND on the FDA’s recent stance on compounded medicine as published in the Journal of Restorative Medicine, Volume 8, Number 1, 4 January 2019,
Academy of Integrative Pain Management Makes Painful Decision to Cease Operations
Lenexa, KS, January 29, 2019 – After thirty years as the nation’s leading voice for integrative pain management, the Academy of Integrative Pain Management (AIPM) will cease operations and solicit members’ permission to dissolve
Plant-Based Food Trend May Lead to Choline Deficiencies
A recent study suggests that the push toward only plant-based diets, without professional nutritional counseling, guidance, and supplementation, may lead to choline deficiencies beyond what is already present. The warning comes from a recent
Commentary from Lisa C. Andrews, MEd, RD, LD on “Physicians Call for Peers to Get Nutrition Education”
Dear Today’s Practitioner, I am writing in response to the article titled Dr. Neal Barnard and other Physicians Call for Peers to Get Nutrition Education in the July issue of Today’s Practitioner. I was very
Glenn Sabin: Joe Biden’s So-Far Missed Opportunity to Impact Cancer
[Disclosure: My explorations of politics on this blog are limited to how political courage and well-expended political capital can have a sustainable impact on reducing our current cancer burden. ~ Glenn Sabin] Given former
The Lancet Journals Announce Diversity Pledge and No “Manel” Policy
As part of the Lancet Group’s commitment to increasing gender equity, diversity, and inclusion in research and publishing, all of the publishing group’s 18 medical journals have adopted a new Diversity Pledge and No
FDA Announces Early Fall Cannabidiol Hearings and Clarifies Commitment to Enforcement
The FDA announced that it will host further cannabidiol hearing on the regulatory structure of CBD products in the early fall. The news was embedded in a press release regarding a warning issued to
FDA Approves Qualified Health Claim for Omega-3 Fatty Acids
Omega-3 fatty acids just received a stamp of approval from FDA for their ability to reduce the risk of hypertension and heart disease. The agency approved a qualified-health claim for Omega 3 fatty acids
Today’s Practitioner Congratulates Joshua Mansour, MD in “40 Under 40” Cancer Award
We are honored to congratulate Today’s Practitioner contributor Joshua Mansour, M.D., who was named one of forty of the nation’s most promising young oncology professionals and recognized during the 2nd annual ‘40 Under 40
International Cannabinoid Research Society (ICRS) Names Cannabis and Cannabinoid Research Its Official Journal
New Rochelle, NY, May 7, 2019—Cannabis and Cannabinoid Research (CCR) is extremely excited to announce that the International Cannabinoid Research Society (ICRS) has named CCR its Official Journal. The ICRS is a foremost international
Biotics Research Corporation, Newest GOED Member
Recently, Biotics Research became the first professional supplement brand in the United States to join the ranks of GOED membership. Formed in 2007, GOED, the Global Organization of EPA and DHA Omega-3s, is comprised
Integrative Healthcare Goes to Washington with the Congressional Integrative Health and Wellness Caucus
Capitol Hill Legislators and Staffers Get a Hands-On Introduction to Integrative Medicine WASHINGTON DC – On March 6, 2019, the second annual Congressional Integrative Health and Wellness Caucus, co-led by Rep. Judy Chu (D-CA),
FDA Commissioner Scott Gottlieb, M.D. on Public Hearing for Cannabis-containing and Cannabis-derived Products
Statement from FDA Commissioner Scott Gottlieb, M.D., on new steps to advance agency’s continued evaluation of potential regulatory pathways for cannabis-containing and cannabis-derived products In recent years, we’ve seen a growing interest in the
Ned Sharpless, MD, from National Cancer Institute (NCI), is Acting Commissioner of the Food and Drug Administration
The White House recently announced its intention to appoint Dr. Ned Sharpless, current director of the National Cancer Institute (NCI), as acting commissioner of the Food and Drug Administration (FDA). Dr. Doug Lowy, current
FDA Commissioner Scott Gottlieb MD Stepping Down
In a surprise announcement, Food and Drug Commissioner Scott Gottlieb MD announced his planned resignation this week, to go into effect in April. Gottlieb became known for his tough stance on tobacco and e-cigarettes
Exclusive Interview with Dr. Paul Anderson: The FDA and the Fate of Compounded Medicines
The following is an excerpt of interview with Paul Anderson, ND on the FDA’s recent stance on compounded medicine as published in the Journal of Restorative Medicine, Volume 8, Number 1, 4 January 2019,
Academy of Integrative Pain Management Makes Painful Decision to Cease Operations
Lenexa, KS, January 29, 2019 – After thirty years as the nation’s leading voice for integrative pain management, the Academy of Integrative Pain Management (AIPM) will cease operations and solicit members’ permission to dissolve
